BR112012020951A2 - compounds as bradykinin-b1 antagonists - Google Patents

compounds as bradykinin-b1 antagonists

Info

Publication number
BR112012020951A2
BR112012020951A2 BR112012020951A BR112012020951A BR112012020951A2 BR 112012020951 A2 BR112012020951 A2 BR 112012020951A2 BR 112012020951 A BR112012020951 A BR 112012020951A BR 112012020951 A BR112012020951 A BR 112012020951A BR 112012020951 A2 BR112012020951 A2 BR 112012020951A2
Authority
BR
Brazil
Prior art keywords
compounds
bradykinin
antagonists
production
salts
Prior art date
Application number
BR112012020951A
Other languages
Portuguese (pt)
Inventor
Angelo Ceci
Annette Schuler-Metz
Dieter Wiedenmayer
Henning Priepke
Henri Doods
Ingo Konetzki
Juergen Mack
Norbert Hauel
Rainer Walter
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2010/052232 external-priority patent/WO2010097372A1/en
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Priority claimed from PCT/EP2011/052512 external-priority patent/WO2011104203A1/en
Publication of BR112012020951A2 publication Critical patent/BR112012020951A2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

compostos como antagonistas de bradiquinina-b1. a presente invenção refere-se a compostos da fórmula geral i, em que n,r1,r2,r3,r4,r5,r6,r7,r8,r9,r10,r11 e x são cada um definidos tal como descrito a seguir, seus enantiômetros, seus diastereômetros, suas misturas e seus sais, especialmente seus sais fisiologicamente compatíves com ácidos ou bases orgâniicos ou inorgânicos, os quais apresentam valiosas propriedades, sua produção, os fármacos contendo os compsotos farmacologicamnete eficazes, sua produção e seu uso.compounds as bradykinin-b1 antagonists. The present invention relates to compounds of the general formula I, wherein n, r 1, r 2, r 3, r 4, r 5, r 6, r 7, r 8, r 9, r 10, r 11 and n are each defined as described below. enantiometers, their diastereometers, their mixtures and their salts, especially their physiologically compatible salts with organic or inorganic acids or bases, which have valuable properties, their production, drugs containing the pharmacologically effective compounds, their production and their use.

BR112012020951A 2010-02-23 2011-02-21 compounds as bradykinin-b1 antagonists BR112012020951A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/EP2010/052232 WO2010097372A1 (en) 2009-02-26 2010-02-23 Compounds as bradykinin b1 antagonists
PCT/EP2011/052512 WO2011104203A1 (en) 2010-02-23 2011-02-21 Compounds as bradykinin b1 antagonists

Publications (1)

Publication Number Publication Date
BR112012020951A2 true BR112012020951A2 (en) 2016-04-26

Family

ID=55859312

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012020951A BR112012020951A2 (en) 2010-02-23 2011-02-21 compounds as bradykinin-b1 antagonists

Country Status (1)

Country Link
BR (1) BR112012020951A2 (en)

Similar Documents

Publication Publication Date Title
BR112014030173A2 (en) benzimidazole proline derivatives
TN2012000417A1 (en) Compounds as bradykinin b1 antagonists
BRPI0607445A2 (en) cis-2,4,5-triaryl imidazolines and their use as anti-cancer medicines
BR112012030820A8 (en) AMINOPYRIMIDINE DERIVATIVES AS LRRK2 MODULATORS, THEIR USE AND COMPOSITION INCLUDING THEM
BR112014011850A2 (en) aminopyrimidine derivatives as lrrk2 modulators
UY33541A (en) N - ((6-AMINO-PIRIDIN-3-IL) -METIL) -HETEROARIL-CARBOXAMIDAS
CY1117792T1 (en) COMPETITORS TOY TRPV4
BR112014013974A2 (en) benzyl sulfonamide derivatives as rorc modulators
BR112014029161A2 (en) unsubstituted benzamides and their use in pain management
BR112014010617A8 (en) 2-(1,2,3-TRIAZOL-2-IL)BENZAMIDE AND 3-(1,2,3-TRIAZOL-2-IL)PICOLINAMIDE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS
UY33458A (en) HETEROCYCLICALLY SUBSTITUTED METOXYPHENYL DERIVATIVES WITH AN OXO GROUP, PROCEDURES FOR THE PREPARATION AND USE OF THE SAME AS MEDICATIONS
BR112013011600A8 (en) Pyrazole aminopyrimidine derivatives as lrrk2 modulators
BR112015007516A2 (en) orexin receptor antagonists that are derived from [ortho-bi- (hetero-) aryl] - [2- (meta-bi- (hetero-) aryl) -pyrrolidin-1-yl] -methanone
BR112014027117A8 (en) PYRAZOLE AMINOPYRIMIDINE DERIVATIVES AS LRRK2 MODULATORS, THEIR USES, AND COMPOSITION
BR112012032748A2 (en) "ringed pyridine compounds"
BR112019001551A2 (en) cxcr7 piperidine receptor modulators
BR112015013463A2 (en) indole carboxamide derivatives as p2x7 receptor antagonists
UY31644A1 (en) IMIDAZOLINE -2,4-DIONAS REPLACED, PROCESSES FOR THEIR PREPARATION, MEDICINES THAT UNDERSTAND THESE COMPOUNDS AND USE OF THE SAME.
BR112013003752A2 (en) disubstituted tetrahydrofuranyl compounds as bradykinin b1 receptor antagonists
BR112016011016A8 (en) phenoxyethyl derivatives of cyclic amine, their uses, and pharmaceutical composition.
BR112014017735A8 (en) HETEROCYCLIC AMIDE DERIVATIVE COMPOUNDS AS P2X7 RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITION, AND USE OF A COMPOUND
BR112012012261A2 (en) compounds as receptor modulators of therapeutic utility
MX2012009224A (en) Compounds as bradykinin b1 antagonists.
BR112014012459A2 (en) 2h-indazoles as ep2 receptor antagonists
UY32404A (en) 4-ARIL-BUTAN-1,3-DIAMIDS

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]